Biolinq
PrivateLast Round
Series C
Apr 22, 2025
Total Funding Raised
$214.75M
Company Overview
Biolinq is a health technology company that develops a biomonitoring platform featuring a skin-applied, minimally-invasive electrochemical biosensor for monitoring multiple analytes like glucose, ketones, and lactate, providing users with actionable insights to enhance metabolic health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Semiconductors
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolinq Comps
Public and private peers based on sector, stage, and business model.
Biolinq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 22, 2025 | ||||
| VC Round | Apr 4, 2024 | ||||
| Series B | Nov 2, 2021 | ||||
| Series A Extension | Mar 28, 2019 | ||||
| Series A | Nov 27, 2017 |
Key People
Founding team and executive leadership
Biolinq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Senvest Capital | Series B |
| Grey Sky Venture Partners | Series A |
| Alpha Wave Ventures | Series C, VC Round |
| LifeSci Venture Partners | Series C, Series A, Series A Extension |
| Aphelion Capital | Series C, VC Round, Series B, Series A Extension |
| Able Partners | Series B |
| Senvest Management | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
Job posting discloses that Biolinq is a clinical stage medical device company, indicating its biosensor platform is undergoing clinical trials.
- Apr 22, 2025
Raised $100M in Series C funding.
Biolinq Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biolinq's valuation, stock price, and market status.
